Related Experiment Video
Updated: Dec 12, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Comparison of FlowGate2 and Merci as balloon guide catheters used in mechanical thrombectomies for stroke
Ho Jun Yi1,2, Dong Hoon Lee1, Jae Hoon Sung1
1Department of Neurosurgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Gyeonggi-do 16247, Republic of Korea.
Abstract:
The present study reports on the usefulness of FlowGate2 (FG2) as a novel balloon guide catheter (BGC) for mechanical thrombectomy (MT) treatment. MT using a BGC device was performed on 255 patients at the authors' institution (St. Vincent's hospital, Suwon, Korea and Hangang Sacred Heart Hospital, Seoul, Korea) between January 2014 and September 2018. A total of 235 patients underwent successful application of BGCs and were divided into two groups; an FG2 and a Merci group, and a comparative analysis was performed. The failure rate in the FG2 group (2.5%) was significantly lower than that in the Merci group (10.8%; P=0.016). Occurrence of distal emboli was significantly lower in the FG2 group (4.7%) than in the Merci group (7.3%; P=0.012). According to subgroup analysis of the BGC and the intermediate catheter, the incidence rate of the distal emboli in the FG2 with an intermediate catheter (2.3%) was significantly lower than that of the Merci with an intermediate catheter (6.6%; P=0.038). The ratio of thrombolysis in cerebral infarction (TICI) 3 recanalization in the first pass was higher in the FG2 group than in the Merci group, in both total (44.7 vs. 34.7%; P=0.033) and subgroup patients (46.5 vs. 34.4%; P=0.029). In the multivariate analysis, use of an intermediate catheter [odds ratio (OR), 0.75; 95% confidence interval (CI), 0.66-0.94; P=0.029] and FG2 application (OR, 0.59; 95% CI, 0.25-0.93; P=0.020) were the predictive factors for fewer distal emboli. In summary, FG2 BGC enables an effective MT with less application failures and occurrence of distal emboli, and higher TICI 3 recanalization at the first stent passage, compared with Merci BGC.

